Chronic myeloid leukemia and resistance to tyrosine kinase inhibitors: ABL mutations, much ado about nothing?

被引:0
|
作者
Gomez Casares, Maria Teresa [1 ]
Leon, Leticia G. [1 ]
机构
[1] Hosp Univ Dr Negrin, Serv Hematol, Mol Biol Lab, Las Palmas Gran Canaria, Spain
来源
MEDICINA CLINICA | 2013年 / 141卷 / 03期
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; GIMEMA WORKING PARTY; CHROMOSOMAL-ABNORMALITIES; IMATINIB; INTOLERANT; FREQUENCY; THERAPY; BCR/ABL; CML;
D O I
10.1016/j.medcli.2012.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:111 / 113
页数:3
相关论文
共 50 条
  • [1] ABL Kinase Domain Mutations in Iranian Chronic Myeloid Leukemia Patients with Resistance to Tyrosine Kinase Inhibitors
    Shojaei, Mahboobeh
    Rezvani, Hamid
    Azarkeivan, Azita
    Poopak, Behzad
    LABORATORY MEDICINE, 2021, 52 (02) : 158 - 167
  • [2] Mutations of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Kihel, I.
    Nachi, M.
    Bekadja, M. A.
    CLINICA CHIMICA ACTA, 2022, 530 : S334 - S335
  • [3] Analysis of ABL Kinase Domain Mutations Conferring Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Cases from India
    Bagadi, Sarita
    Saikia, Tapan
    Pany, Ayaskant
    Das, Bibhu
    CLINICAL LABORATORY, 2011, 57 (7-8) : 619 - 623
  • [4] Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Lion, T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S3 - S3
  • [5] ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance
    Vacarean-Trandafir, Irina Cezara
    Ivanov, Iuliu Cristian
    Dragos, Loredana Mihaiela
    Dascalescu, Angela Smaranda
    Titieanu, Amalia Andrea
    Cojocaru, Dumitru
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (04) : 3747 - 3754
  • [6] ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance
    Irina Cezara Vacarean-Trandafir
    Iuliu Cristian Ivanov
    Loredana Mihaiela Dragos
    Angela Smaranda Dascalescu
    Amalia Andrea Titieanu
    Dumitru Cojocaru
    Molecular Biology Reports, 2019, 46 : 3747 - 3754
  • [7] Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
    Erbilgin, Yucel
    Eskazan, Ahmet Emre
    Ng, Ozden Hatirnaz
    Salihoglu, Ayse
    Elverdi, Tugrul
    Firtina, Sinem
    Tasar, Orcun
    Mercan, Sevcan
    Sisko, Sinem
    Khodzhaev, Khusan
    Ongoren, Seniz
    Ar, Muhlis Cem
    Baslar, Zafer
    Soysal, Teoman
    Sayitoglu, Muge
    Ozbek, Ugur
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 200 - 207
  • [8] BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival
    Barbosa Pagnano, Katia Borgia
    Bendit, Israel
    Boquimpani, Carla
    De Souza, Carmino Antonio
    Miranda, Eliana C. M.
    Zalcberg, Ilana
    Larripa, Irene
    Nardinelli, Luciana
    Silveira, Rosana Antunes
    Fogliatto, Laura
    Spector, Nelson
    Funke, Vaneuza
    Pasquini, Ricardo
    Hungria, Vania
    Chiattone, Carlos Sergio
    Clementino, Nelma
    Conchon, Monika
    Beatriz Moiraghi, Elena
    Lopez, Jose Luis
    Pavlovsky, Carolina
    Pavlovsky, Miguel A.
    Cervera, Eduardo E.
    Antonio Meillon, Luis
    Simoes, Belinda
    Hamerschlak, Nelson
    Magarinos Bozzano, Alicia Helena
    Mayta, Ernesto
    Cortes, Jorge
    Bengio, Raquel M.
    CANCER INVESTIGATION, 2015, 33 (09) : 451 - 458
  • [9] ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
    Ernst, Thomas
    Hoffmann, Jana
    Erben, Philipp
    Hanfstein, Benjamin
    Leitner, Armin
    Hehlmann, Ruediger
    Hochhaus, Andreas
    Mueller, Martin C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (09): : 1389 - 1393
  • [10] Complexity of BCR-ABL kinase domain mutations during the course of therapy with tyrosine kinase inhibitors in chronic myeloid leukemia
    Verma, Dushyant
    Fava, Carmen
    Kantarjian, Hagop
    Cortes, Jorge
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (04) : 256 - 257